Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
CGT Research Outlook and Technology Growth Opportunities
... therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, and expansion to new disease areas. Over ... Read More
-
Angina Pectoris Drugs
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Beta Blockers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.6 Billion by ... Read More
-
Stroke Management
... at a CAGR of 5.4% over the analysis period 2023-2030. Stroke Management Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$35.9 Billion by the end ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
... of Atherosclerotic Cardiovascular Disease in the 7MM is expected to increase, driven by better diagnosis and launch of emerging therapies. DelveInsight’s analyst projects that among the total cases of ASCVD in 7MM approximately 47% of ... Read More
-
Critical Care Therapeutics
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Albumin Drug Class, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion ... Read More
-
C-Reactive Protein Testing
... by 2030, growing at a CAGR of 1.8% over the analysis period 2023-2030. C-Reactive Protein Testing for Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and ... Read More
-
Global Pediatric Home Healthcare Market Size Study, by Services (Skilled Nursing Services, Personal Care Assistance, Rehabilitation Therapy Services), by Application (Cancer, Respiratory Disease, Cardiovascular Disease, Physical Disabilities, Others), and Regional Forecasts 2022-2032
... Healthcare Market is valued at USD 39.69 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2024-2032. Pediatric home healthcare is a comprehensive, ... Read More
-
Global Predictive Presymptomatic Testing Market 2024-2028
... forecast period. The report on the predictive presymptomatic testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Drug-Coated Balloons Market - Focused Insights 2024-2029
... with DCB The growing burden of cardiovascular diseases is accelerating the continued development of interventional cardiology and has led to the development of drug-coated balloons. Traditional metallic stents represent several limitations in interventional cardiology, where ... Read More
-
Global Peripheral Artery Disease Market Size Study, by Product Type (Devices, Drugs), by End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers), and Regional Forecasts 2022-2032
... 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2024-2032. Peripheral artery disease (PAD) is characterized by the narrowing or blockage of ... Read More
-
Global Cardiac Biomarkers Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 1310.7 million by 2030 with a CAGR of 8.8% during review period. Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally ... Read More
-
Global Acute Rehabilitation Market Size Study, by Phase Type (Phase I- Acute Phase, Phase II- Subacute Phase, Phase III- Intensive Outpatient Therapy, Phase IV- Independent Ongoing Conditioning), by Devices Product (Blood Pressure Monitor, Heart Rate Monitor, Rower, Seated & Upright Elliptical Trainer, Stabilization Ball, Stationary Bicycle, Treadmill), by Disease Type (Abnormal Heart Rhythms, Angina, Atrial Fibrillation, Cholesterol Management, Coronary Artery Bypass Surgery, Coronary or Peripheral Artery Disease, Diabetes, Heart Failure or Transplant, High Blood Pressure, Pulmonary Hypertension), by End User (Home Care, Hospitals & Clinics, Rehabilitation Centers, Specialty Centers), and Regional Forecasts 2022-2032
... Monitor, Rower, Seated & Upright Elliptical Trainer, Stabilization Ball, Stationary Bicycle, Treadmill), by Disease Type (Abnormal Heart Rhythms, Angina, Atrial Fibrillation, Cholesterol Management, Coronary Artery Bypass Surgery, Coronary or Peripheral Artery Disease, Diabetes, Heart Failure ... Read More
-
Global Diuretic Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Statin Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Cardiovascular Drugs Industry Forecasts - China Focus
... manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China ... Read More
-
Cardiovascular Drugs Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Cardiovascular Drugs Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Cholesterol Testing
... at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More
-
Perfusion Systems
... at a CAGR of 4.3% over the analysis period 2023-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$671.0 Million by the end ... Read More
-
Atrial Fibrillation Devices
... by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. EP Ablation Catheters, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$4.8 Billion ... Read More
-
Cardiology IT Workflow Solutions
... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
Cardiovascular Catheters
... at a CAGR of 6.5% over the analysis period 2023-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$25.4 Billion by the end ... Read More
-
Carotid Stents
... at a CAGR of 8.7% over the analysis period 2023-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$4.3 Billion by the end ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
Research Assistance
